Company intelligence
IGI
Ichnos Glenmark Innovation
Biotechnology
New York, US
279 employees
Founded 2019
2 public signals
About IGI
IGI, Inc. is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing a robust pipeline of novel, first-in-class Multispecifics™ aimed at addressing complex diseases and treating patients holistically. Powered by its proprietary BEAT® technology platform, IGI is committed to delivering breakthrough, curative therapies to improve and extend the lives of patients battling hematological malignancies and solid tumors.
Verified activity
Signals from IGI
2 published signals
Presence & Recognition
IGI attended the Society for Clinical Data Management (SCDM) Annual Conference 2026 next week.
Reported by Kelly Swinson
Presence & Recognition
IGI President and CEO Lida Pacaud MD attended an interview with Scrip highlighting IGI's breakthrough multispecific immunotherapy platform BEAT for solid tumors
Reported by IGI